EBV Strategies to Counteract the Immune Response

8,506
Total downloads
43k
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Published on 29 Nov 2024

Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+KIR+CD56dim subsets

Maria Giovanna Desimio
Daniela Angela Covino
Caterina Cancrini
Margherita Doria

doi 10.3389/fimmu.2024.1467304

837 views

REVIEW

Published on 09 Jul 2024

Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis

Manuel Ruiz-Pablos
Bruno Paiva
Aintzane Zabaleta

doi 10.3389/fimmu.2024.1422940

16,361 views
1 citation

REVIEW

Published on 07 Feb 2024

Epstein-Barr virus: the mastermind of immune chaos

Jean de Melo Silva
Carlos Eduardo de Castro Alves
Gemilson Soares Pontes

doi 10.3389/fimmu.2024.1297994

15,207 views
22 citations

REVIEW

Published on 21 Dec 2023

Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival

D. G. Sausen
M. C. Poirier
L. M. Spiers
E. N. Smith

doi 10.3389/fimmu.2023.1289313

2,934 views
6 citations

ORIGINAL RESEARCH

Published on 22 Jun 2023

Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas

Hannes Vietzen
Philipp B. Staber
Sarah M. Berger
Philippe L. Furlano
Laura M. Kühner
Simone Lubowitzki
Alexander Pichler
Robert Strassl
Jan J. Cornelissen
Elisabeth Puchhammer-Stöckl

doi 10.3389/fimmu.2023.1183788

2,555 views
8 citations

Share on

Frontiers in Immunology

Frontiers in Immunology

Viral Immunology

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

43kTopic views
34kArticle views
8,506Article downloads